ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BYOT Byotrol Plc

0.125
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Byotrol Plc LSE:BYOT London Ordinary Share GB00B0999995 ORDS 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.125 0.05 0.20 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Chemicals & Chem Preps, Nec 4.59M -1.69M -0.0037 -0.32 544.67k

Byotrol PLC Appointment of New Director & Award of Options (3213O)

29/01/2019 7:00am

UK Regulatory


Byotrol (LSE:BYOT)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Byotrol Charts.

TIDMBYOT

RNS Number : 3213O

Byotrol PLC

29 January 2019

Byotrol plc

("Byotrol", " or the "Company")

Appointment of Non-Executive Director

Award of Options

Byotrol plc, the AIM listed anti-microbial technology company, is pleased to announce the appointment of Sean Gogarty as a Non-Executive Director of the Company with effect from 29 January 2019.

Sean Gogarty, 53, has a wealth of experience developing and running branded businesses, gained particularly from a 20-year career at Unilever, where his roles included Global CEO Unilever Baking, Cooking and Spreads, and Global Category SVP Household Cleaners. In the latter role, he led the rapid growth of a number of well-known household brands, including Domestos, Cif, Lysoform and Sunlight, from a sales value of E800m to over E2.5bn.

Having started his career in the media sector before moving into industry, Sean also has a strong track record of advising a range of leading PE firms and companies on developing business strategies, brand portfolio plans, organisational structures and supply chain strategies. He also acts as a Non-Executive Director at The Marketing Group plc.

The Company has granted Sean Gogarty options over 2,000,000 shares under the Byotrol plc unapproved share option scheme at a strike price of 2.1p. These options are exercisable in three tranches from 29 January 2020, 2021 and 2022 subject to the Company's share price reaching hurdles of 3p, 5p and 7p.

At the date of this announcement, Mr Gogarty does not have any beneficial interest in the ordinary shares of the Company.

John Langlands, Chairman of the Company, said,

"We are delighted to welcome Sean to the Board of the Byotrol. He has a wealth of experience from his time at Unilever and has a strong record of developing leading global brands and strategies. His considerable experience in both executive and non-executive roles in a wide range of consumer facing businesses will be invaluable to us as we continue to grow and develop Byotrol."

 
 Current directorships and/or partnerships:   Former directorships and/or 
                                               partnerships (within the last 
                                               five years): 
 The Marketing Group plc                      Upfield Spreads UK Limited 
 Style Media Ltd 
 Mahee-Mountain Ltd 
 Grove Strategic Advisors Limited 
 Desire Brands Ltd 
 Ice-Sight Limited 
 Style Retail Ltd 
 Slicethepie Ltd 
 

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

Enquiries:

Byotrol plc 01925 742 000

John Langlands - Chairman

David Traynor - Chief Executive

finnCap Ltd 020 7220 0500

Geoff Nash / Kate Bannatyne - Corporate Finance

Richard Chambers - ECM

Notes to Editors:

Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.

Our patented suite of technologies deliver powerful, broad-spectrum efficacy, optimised against commonly-occurring and industry-specific pathogens.

Founded in 2005, the Company seeks to develop and commercialise advanced antimicrobial technologies that create easier, safer and cleaner lives for everyone.

For more information, please go to www.byotrol.co.uk

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

 
        1.   Details of the person discharging managerial responsibilities 
              / person closely associated 
 a)          Name                             Sean Gogarty 
            -------------------------------  -------------------------------------- 
        2.   Reason for the Notification 
            ----------------------------------------------------------------------- 
 a)          Position/status                  NED 
            -------------------------------  -------------------------------------- 
 b)          Initial notification/Amendment   Initial 
            -------------------------------  -------------------------------------- 
 3.          Details of the issuer, emission allowance market participant, 
              auction platform, auctioneer or auction monitor 
            ----------------------------------------------------------------------- 
 a)          Name                             Byotrol Plc 
            -------------------------------  -------------------------------------- 
 b)          LEI                              213800AJMTSTIPA59A34 
            -------------------------------  -------------------------------------- 
 4.          Details of the transaction(s): section to be repeated 
              for (i) each type of instrument; (ii) each type of transaction; 
              (iii) each date; and (iv) each place where transactions 
              have been conducted 
            ----------------------------------------------------------------------- 
 a)          Description of the               options over ordinary shares of 0.25p 
              Financial instrument,            each 
              type of instrument 
             Identification code              GB00B0999995 
            -------------------------------  -------------------------------------- 
 b)          Nature of the transaction        Award of Options to subscribe for 
                                               Ordinary Shares 
            -------------------------------  -------------------------------------- 
 c)          Price(s) and volume(s)           Volume - 2,000,000 
                                               Exercise Price - 2.1 pence 
            -------------------------------  -------------------------------------- 
 d)          Aggregated information:          See 4c) above 
            -------------------------------  -------------------------------------- 
 e)          Date of the transaction          29 January 2019 
            -------------------------------  -------------------------------------- 
 f)          Place of the transaction         Outside of a trading venue 
            -------------------------------  -------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCDMGZMVRRGLZM

(END) Dow Jones Newswires

January 29, 2019 02:00 ET (07:00 GMT)

1 Year Byotrol Chart

1 Year Byotrol Chart

1 Month Byotrol Chart

1 Month Byotrol Chart

Your Recent History

Delayed Upgrade Clock